The group devises new therapeutic strategies targeting tumour-associated immune landscape, stroma and vasculature.
Dr Olivia Rossanese is Director of the Centre for Cancer Drug Discovery and Head of the Division of Cancer Therapeutics. She is investigating new therapeutic targets for the treatment of cancer and examining the molecular consequences of their inhibition in cancer cells and tumours.